Through cutting-edge research, development, and clinical testing, Opto is forging a path toward creating safe, effective, and minimally invasive implants that can significantly improve patient outcomes and change treatment.
Opto is led and co-founded by Ben Woodington (ex-medical device engineer and bioelectronics researcher) and Elise Jenkins (electrical engineer turned neuro-oncology researcher) who undertook their PhDs in the Bioelectronics Laboratory at the University of Cambridge. Its founding team and advisors have spent years discussing the immense possibilities and gaps within neurological treatment and monitoring.
It's a little quiet here. Head over to the Media Hub to discover stories, listen to podcasts, watch videos, and more.Go to Media Hub